When healthcare professionals buy or sell a practice, legal preparation is rarely the first priority. Valuation, financing, and timing tend to dominate the early conversation. Legal structure gets addressed later, often too late.

That sequencing error is expensive. The legal framework of a practice transaction determines what is actually being transferred, what liabilities may remain, what approvals are required, and whether the deal can close and operate as intended afterward. In healthcare, those questions are more complex than in most industries. Ordinary business-contract issues intersect with licensing, reimbursement, privacy, fraud-and-abuse exposure, and state-specific employment restrictions. Problems identified late are harder and more expensive to solve, and in some cases, cannot be solved at all without renegotiating terms both parties believed were settled.

Below are five legal mistakes that recur across healthcare practice transactions, and what to do about each.

1. Treating the Letter of Intent as a Formality

Letters of intent in healthcare transactions are routinely underestimated by both sides. Sellers sometimes view them as a soft handshake, an expression of intent rather than a meaningful document. Buyers sometimes treat them as a placeholder while they continue evaluating the opportunity.

Neither approach is correct.

An LOI sets the economic framework for the transaction: price, structure, exclusivity, and the basic allocation of risk. Once signed, it creates expectations that are difficult to unwind. While most business terms in an LOI are nonbinding, other provisions, including exclusivity, confidentiality, expense allocation, governing law, and dispute-resolution terms, are often drafted to bind immediately. That distinction matters and is frequently misunderstood.

If the LOI is vague or internally inconsistent, the parties often discover, deep into diligence, that they never shared the same understanding of key issues: whether the transaction is an asset sale or equity sale, what assets and liabilities are included, whether accounts receivable or working capital are part of the deal, what post-closing employment obligations apply, and whether closing is conditioned on landlord consent, payer enrollment, financing, or regulatory approvals. Each of those gaps can cause delays, disputes, or failed transactions.

A well-drafted LOI does more than allocate risk. It signals to the other side that the transaction is being taken seriously. A document that is precise, internally consistent, and reflects real preparation tells a seller or buyer that the party on the other side of the table is professional, organized, and prepared to move forward. That signal matters practically: it tends to prompt reciprocal seriousness, faster responsiveness, and a counterparty willing to commit real time and resources to the process, rather than treating the LOI as a starting point for renegotiation. A sloppy or ambiguous LOI sends the opposite signal, and often gets treated accordingly.

What to do: Engage legal counsel before the LOI is signed, not after. The LOI is not a formality, it is the document that frames everything that follows.

2. Assuming Restrictive Covenants Are Enforceable

Non-compete, non-solicitation, and confidentiality covenants are central to the value of most healthcare practice acquisitions. A buyer is paying, in large part, for goodwill: the ongoing relationship between the practice and its patient base.

Restrictive covenants against the selling doctor are generally enforceable, and are a standard, expected term in a practice sale. The seller is being paid for goodwill, and in exchange, agrees not to compete for it. That part of the equation is usually straightforward.

Associates are a different question, and one that matters more as a practice grows. In a single-doctor practice being sold doctor-to-doctor, associate coverage may be less central to the deal. But in larger, multi-doctor practices, retaining associates after closing is often critical to preserving the revenue the buyer is paying for. If an associate is free to leave and compete nearby, the goodwill attributed to that associate’s production can erode quickly, regardless of what the seller’s own covenant says.

The problem is that associate-level enforceability varies significantly by jurisdiction, and many buyers do not find this out until after the deal closes. California substantially restricts non-compete agreements generally, with limited exceptions. Several other states have moved in a similar direction or impose meaningful restrictions on scope and duration. Some states apply occupation-specific rules for physicians and other licensed professionals that further limit what restrictions are permissible. A covenant that appears protective on paper may offer little or no actual protection under applicable law.

This has structural consequences. If associate non-competes are unenforceable in the relevant jurisdiction, the buyer’s assumptions about post-closing revenue durability need to be tested, and the purchase price should reflect that reality. It also changes what other protections need to be built into the transaction: stronger confidentiality provisions, non-solicitation agreements to the extent they are enforceable, and transition planning designed to reduce the risk of patient attrition in the first place.

Employment and contract documentation needs the same scrutiny. Selling doctors should have their own employment agreements, along with any associate or key-employee contracts, fully executed and organized well before a transaction reaches diligence. A buyer evaluating a practice needs a clear, current picture of who is under contract, on what terms, and what obligations survive a change of ownership. Disorganized or missing documentation on this front is not a minor administrative gap; it leaves a buyer unable to assess exactly what they are acquiring.

What to do: Before closing, assess which covenants are already in place at both the seller and associate level, whether they are enforceable under the law of the relevant state, and what new agreements should be executed at closing with employees the buyer intends to retain. In larger practices, associate retention and enforceability deserve a dedicated diligence focus. Do not assume an agreement is enforceable because it was signed, and do not proceed without organized documentation of every employment relationship the practice depends on.

3. Treating Billing History as Only a Financial Issue

Revenue history in a healthcare practice is not simply a financial question, it is a legal one.

Practices that have engaged in improper billing like upcoding, unbundling, billing under incorrect provider credentials, or submitting claims for services not documented as delivered, carry regulatory and legal exposure that does not automatically disappear in a transaction. Knowingly submitting false or fraudulent claims to a federal payer can create liability for the party responsible, and depending on the facts, other issues may also be implicated: overpayment-refund obligations, anti-kickback concerns, and payer-contract violations.

What many buyers do not appreciate is that an asset purchase structure does not guarantee a clean break from the seller’s pre-closing conduct. Successor-liability exposure is fact-specific, and outcomes can turn on the transaction structure, the continuity of operations, whether the buyer had notice of potential issues, and applicable law. Buyers who assume an asset purchase automatically extinguishes pre-closing exposure take a risk the structure may not support.

Diligence must go beyond the profit-and-loss statement. Buyers should review coding and billing policies, sample claims and supporting documentation, payer correspondence, prior audits, overpayment demands and refund activity, pending investigations or self-disclosures, enrollment status, and compliance program materials. If a practice’s revenue appears inconsistent with its patient volume, procedure mix, or staffing level, that discrepancy requires a specific explanation before closing.

What to do: Build billing and reimbursement compliance review into the diligence process as a legal matter from the outset. Representations, warranties, indemnification provisions, and escrows in the purchase agreement can help allocate risk, but they are not substitutes for understanding what the practice’s billing history actually reflects.

4. Deferring the Lease Until the End of the Process

The office lease is treated as secondary in many healthcare transactions. Buyers and sellers agree on price, negotiate employment terms, work through diligence, and then, often late in the process, turn their attention to real estate.

That sequencing creates avoidable risk.

The lease is not an ancillary document. It is a foundational one that affects lender approval, long-term operational stability, and deal economics. A practice may have strong cash flow and favorable purchase terms, but if the lease cannot be assigned, extended, or renegotiated on acceptable terms, the transaction can become significantly less attractive, or not viable at all.

Lease issues that commonly surface late and cause friction include: landlord-consent requirements for assignment or change of control; remaining term too short for financing or operational stability; personal guaranty obligations; use restrictions; rent escalations and common-area charges; maintenance and build-out obligations; and weak or absent renewal options. For buyers and lenders, these are material underwriting concerns, not administrative details.

When these issues emerge during the final stages of a transaction, the parties face a constrained set of choices: delay closing, accept worse terms, or lose the deal.

What to do: Review the lease early, before price is finalized and before lender submissions are made. Confirm whether the transaction triggers assignment, consent, or change-of-control provisions, and whether the remaining term and renewal rights are adequate. If landlord consent is required, begin that process on a timeline that does not compress against the closing date.

5. Good Counsel Saves Money and Increases Return on Investment

One of the most common legal mistakes in healthcare practice transactions is treating legal counsel as a late-stage necessity rather than an early driver of value. Engaged early, the right counsel does more than avoid problems, it improves pricing, structure, and execution in ways that directly affect return.

When legal counsel is introduced after price is agreed, structure is set, and the LOI is signed, the attorney’s role becomes corrective rather than strategic. Instead of shaping the transaction, counsel is asked to document a structure that may already contain unresolved problems, an impermissible ownership structure under state law, a licensure or enrollment obstacle, an unenforceable covenant, a fraud-and-abuse concern, a lease problem, or a tax treatment that does not match what the parties intended. Late-stage corrections are slower, more expensive, and more likely to force renegotiation when timelines are tight and both parties are already committed to closing.

In healthcare transactions specifically, the legal complexity is not limited to contract mechanics. Regulatory issues, including corporate practice of medicine restrictions, healthcare entity structure requirements, payer enrollment, and privacy compliance, can affect whether a proposed transaction structure is permissible at all. Attorneys with sophisticated business acumen and healthcare-specific transaction experience can identify those issues early, when there are still options. Discovered late, the same issues become closing conditions under pressure.

What to do: Involve legal counsel early, not as a cost center, but as a transaction advisor who understands deal mechanics, the regulatory environment, and the practical realities of healthcare practice ownership. The cost of early involvement is consistently a fraction of the cost of correcting problems that should never have been allowed to harden, and it positions the transaction to close on terms that reflect its actual value.

A Final Point on Preparation

Each of these legal mistakes shares a common root: business decisions made before the legal and structural implications were fully assessed. In healthcare practice transactions, the legal work is not administrative, it shapes what the transaction is, whether it can close, and whether it holds together after closing.

Healthcare professionals who approach these transactions with that understanding, and who engage experienced counsel early enough to actually influence structure, consistently reach better outcomes than those who treat legal review as a final step.

Schedule a Confidential Consultation

Morgan Advisory Group represents physicians, dentists, veterinarians, and healthcare investors in practice transactions across the country. The firm’s work is concentrated in dental practice acquisitions, commercial lease negotiation, and outside general counsel services for healthcare practice owners. To schedule a confidential consultation, contact the firm directly.